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Abstract
Background: Remifentanil induced hyperalgesia (RIH) is characterized by stimulation evoked pain including allodynia
and thermal hyperalgesia after remifentanil infusion. N-methyl-D-aspartate (NMDA) receptor was reported to be involved
in the progress of RIH. We hypothesized that intrathecal MgSO4 could relieve hyperalgesia after remifentanil infusion via
regulating phosphorylation of NMDA receptor NR2B subunit activity in this study.
Methods: Thirty two rats were randomly allocated into control group, model of RIH group, RIH plus 100ug MgSO4
group, RIH plus 300ug MgSO4 group. Mechanical and thermal hyperalgesia were tested at -24
th h, 2nd h, 6th h, 24th h,
48th h after remifentanil infusion. Following sacrifice of rats after the last behavioral test, we performed the western blot
to detect the expression of spinal phosphorylated NMDA receptor NR2B subunit (pNR2B) in the L4-L5 segments.
Results: Intrathecal MgSO4 (100, 300 μg) dose-dependently reduced thermal and mechanical hyperalgesia from 2 h to
48 h after remifentanil infusion. Remifentanil infusion remarkably stimulated the expression of pNR2B. Nevertheless, the
increased amount of pNR2B by RIH was dose-dependently suppressed by intrathecal infusion of MgSO4 in rats.
Conclusions: Remifentanil induced hyperalgesia/allodynia could be ameliorated by Mg-mediated blockade targeting
the NR2B subunit in NMDA receptors.
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Background
Due to the property of rapid onset and recovery, remifen-
tanil is quite widely used in clinic. However, remifentanil
was reported to be associated with the development of
hyperalgesia. it was noted that general anesthesia based on
remifentanil infusion resulted in severe postoperative pain
after surgery [1]. Additionally, analgesic consumption after
operation can be increased following the intraoperative
use of remifentanil [2].
N-methyl-D aspartate (NMDA) receptors was known
to play a critical role in excitatory synaptic transmission.
Remifentanil could enhance the activation of spinal
NMDA receptor, which was attributed to the progress of
remifentanil induced hyperalgesia (RIH) [3].
NR2B subunit is an essential part in the NMDA recep-
tors. Tyrosine-1472 phosphorylation in NR2B is known
to be associated with neuropathological conditions [4].
Phosphorylation of Tyr-1472 in NR2B (pNR2B) has pre-
viously been demonstrated in the progress of RIH [5].
NMDA receptor antagonist was implicated to decrease
the extended area of RIH in human [6]. Prior administra-
tion of magnesium could inhibit delayed fentanyl induced
hyperalgesia [7, 8] in rats. Our previous study suggested
that magnesium sulphate could dose-dependently inhibit
RIH in rats [9]. The purpose of this study was to explore
whether intrathecal magnesium administration could
* Correspondence: szyangjp@126.com
1Department of Anesthesiology, 1st Affiliated hospital, Soochow University,
188#, Shizi Street, Gusu District, Suzhou 215000, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sun et al. BMC Anesthesiology  (2017) 17:30 
DOI 10.1186/s12871-017-0325-3
prevent RIH via decreasing the amount of pNR2B expres-
sion in superficial dorsal horn of spinal cord.
Methods
Animals
After approval of experimental animal center of
Wenzhou Medical university, Adult male Sprague–
Dawley rats (230 ± 30 g) were obtained and main-
tained under a 12 h light −12 h dark cycle with food
and water freely available.
Intrathecal catheter placement
Intrathecally catheterization was performed after an
acclimation period of at least 5 days for the rats. Under
sevoflurane anesthesia, plastic PE-10 tube (OD: 0.5 mm,
ID: 0.25 mm, AniLab Co. Ltd, China) was implanted into
intrathecal space. The rostral part of the catheter was
then sutured to the muscle to immobilize it.
Surgical procedure
Under sevoflurane anesthesia, a longitudinal incision
(0.8 cm) was made starting from edge of the heel and
extending toward the toes of the right hind paw. The
underlying plantaris muscle was exposed and incised
longitudinally, leaving the muscle origin and insertion
intact. After hemostasis, skin was closed covered with
antiseptic gauze.
Remifentanil infusion
Remifentanil (1.2 μg.kg−1.min−1) was infused via tail vein
over a period of 60 min using a pump.
Behavioral test
Mechanical nociception was determined by measuring
paw withdrawal mechanical thresholds (PWMT).
Through a mesh bottom (1 × 1 cm), the electronic von
Frey filament (0.8 mm diameter, LS instrument, USA)
was applied vertically to the plantar surface of the right
hind paw. Positive nociceptive-like response was defined
as clear paw withdrawal or licking.
Thermal nociception was determined by measuring
paw withdrawal thermal latency (PWTL) using thermal
stimulation system (Model 336, Series 8, IITC INC,
USA). A radiant thermal source below a glass floor
(5 mm thick) was positioned to deliver a thermal stimu-
lus to the midplantar region adjacent to the wound of
right hind paw. When the rat had response of clear paw
withdrawal or flinching, the thermal source was
switched off, and the timer stopped, measuring the
PWTL. Thermal stimulation was automatically cut off
after 25 s if the rat fails to withdraw.
Animals were allowed to acclimatize for 30 min before
testing. Mean PWTL and PWMT were established by
averaging the values of three tests with a five minute
interval between each test.
Drugs
Remifentanil hydrochloride (Ultiva) (batch number:
6587129, Ren Fu Co, China), Magnesium sulfate
(M2643, Sigma. St. Louis, USA), sevoflurane (batch
number: 4Z132, maruishi-pharm.co. Japan).
Western blotting
After the last behavioral test, the animals were sacrificed
with sevoflurane and lumbar spinal cord L4-L5 segments
were removed in 2 min. Tissue samples were homoge-
nized in lysis buffer containing protease inhibitors
(Sigma-Aldrich Co.). The homogenate was centrifuged
at 12,000 rpm for 5 min at 4 °C and supernatant was
removed as the total protein. Proteins (70 μg) were sepa-
rated on a 7.5% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to poly-
vinylidene difluoride membrane (Bio-Rad, CA) with a
Trans-Blot Transfer Cell system (Bio-Rad, CA). The
filters were blocked with 5% nonfat milk in TBS buffer
at room temperature for 1 h. Then the blot was
incubated with the primary antibody against phosphory-
lated Tyr 1472 NR2B (1:1000; Cell signaling Technology,
USA) overnight at 4 °C. The membrane was washed with
TBS buffer and incubated for 1 h with the secondary
anti- rabbit IgG horseradish peroxidase (1:2000; Jackson
ImmunoResearch, USA) at room temperature and
visualized in enhanced chemiluminescence solution
(Amersham Biosciences) followed by film exposure.
β-Actin was used as endogenous control (1:10,000, Bio-
technology, USA). Those who did the western blot were
blinded to the group allocation. Densitometric quantifi-
cation of each specific band was performed using Gene
Tools Match software (Syngene, Cambridge, UK). The
results were expressed as the percentage of β-actin
immunoreactivity.
Experiment protocol
Experiments were performed 7 days later after intra-
thecal catheterization. To evaluate thermal and mechan-
ical hyperalgesia induced by remifentanil, 32 rats were
assigned into the following four experimental groups (n
= 8): 1: Group C (a control group with the administra-
tion of sevoflurane inhalation without incision); 2: Group
RI (model of RIH with surgical procedure and remifen-
tanil infusion, 10 μl normal saline was intrathecally
administration); 3: Group RIM3 (300 μg MgSO4 was
intrathecally given to the group RI); 4: Group RIM1
(100 μg MgSO4 was intrathecally given to the group RI).
30 min before remifentanil infusion and plantar incision,
MgSO4 or normal saline were intrathecally administra-
tion in a volume of 10 μl, followed by additional normal
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saline (20 μl) to flush the catheter. Remifentanil infusion
and plantar incision were performed at the same time.
PWMT and PWTL tests were performed at −24 h, 2 h,
6 h, 24 h, and 48 h after remifentanil infusion. The L4-L5
segments for western blot analysis were collected just
after behavioral testing at 48 h to investigate whether
magnesium could prevent RIH via modulating spinal
pNR2B activity.
All behavioral tests were carried out in a quiet test
room by the same investigator (Doc Lin) who was
blinded to the group allocation.
Statistical analysis
Quantitative parametric data obtained from the groups
were expressed as mean ± SD. Data from thermal and
mechanical hyperalgesia were analyzed using repeated
measures analysis of variance. The expression of pNR2B
across all experimental groups were statistically tested
by one-way ANOVA with Bonferroni correction. The
level of statistical significance was set at p = 0.05. Data
were analyzed with the SPSS 15.0 software (SPSS Inc.,
Chicago, IL, USA).
Result
There were no statistical differences by the basal PWTL and
PWMTvalues among the experimental groups (p > 0.05).
Compared with normal saline, both of 300 μg and
100 μg MgSO4 significantly inhibited thermal (Fig. 1a)
and mechanical (Fig. 1b) hyperalgesia. Compared with
100 μg MgSO4, 300 μg MgSO4 had less thermal hyper-
algesia at 2 h, 6 h, 24 h, 48 h (p = 0.000) and less mech-
anical hyperalgesia at 2 h (p = 0.009),6 h (p = 0.005), 24 h
(p = 0.004). There was no statistical difference in
mechanical hyperalgesia at 48 h (p = 0.286) (Fig. 1,
Additional file 1).
The levels of tyrosine phosphorylated NR2B of NMDA
receptors were significantly lower in GroupRIM3
compared with the levels in GroupRIM1 and Group RI
(p < 0.001). No significant change was detected between
GroupRIM3 and Group C (p = 0.078). (Fig. 2, Additional
file 2).
Discussion and conclusions
In the current study, remifentanil was found to aggravate
both mechanical and thermal hyperalgesia after remifen-
tanil infusion. Intrathecal Mg2+ provided a dose-
dependent anti-nociceptive effect [10]. The authors have
previously demonstrated that the MgSO4 doses of 100ug
and 300 μg were safe for intrathecal injection in rats [9].
MgSO4 was reported to alleviate the hyperalgesia via
inhibiting the tyrosine phosphorylation of NMDA recep-
tor in dorsal horn of lumber spinal cord [11].
Remifentanil was report to induce dose-dependent
hyperalgesia in human [2]. The hyperalgesic effect of
opioid was complicated and was once seemed to be me-
diated by opioid receptors. However, hyperalgesia could
still be provoked by opioid in mice in which μ, κ and δ
opioid receptors were completely knocked out [12, 13].
On the contrary, infusing the opioid could still cause
hyperalgesia instead of analgesia in these knockout mice
[13]. Based on the results of these studies, it is supposed
that opioid-induced hyperalgesia may be explained by
mechanism other than opioid receptors.
MgSO4 in the trial was found to decrease the remifen-
tanil induced hyperalgesia. RIH may be associated with
NMDA activation via an intracellular pathway to
up-regulate the function of NMDA activity [3]. MgSO4
could occlude the Ca2+ ion current, which resulted in a
further release of glutamate and initiating a series of
central sensitization to induce opioid-induced hyperalge-
sia [14, 15]. As illustrated by Angst’s study, even short-
term administration of remifentanil could enhance
hyperalgesia during withdrawal, while ketamine, the
NMDA receptor antagonist, could abolish such hyper-
algesic response [6]. NMDA antagonists could reverse
opioid hyperalgesia by antagonizing NMDA receptors
Fig. 1 a-b Effect of MgSO4 on remifentanil-induced hyperalgesia.
MgSO4 or normal saline were administered intrathecally 30 min before
remifentanil infusion and surgical incision. PWTL (a) and PWMT (b) were
evaluated at 24 h before incision and 2, 6, 24, 48 h. Data are expressed as
means ± SD. * p< 0.001 compared with Group C, # p< 0.001 compared
with Group RI, + p< 0.01 compared with GroupRIM1
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[16]. Taken together, NMDA palyed a key role in
pathogenesis of RIH.
Distribution of NMDA receptor NR2B was demon-
strated to almost limit in the superficial dorsal horn
[17]. The spinal sensitization and increased nociceptive
input may present due to the condition that noxious
stimulus occurred within the superficial dorsal horn in
the central primary afferent terminals. Subsequently,
nociceptive substances such as glutamic acids activate
the specific nociceptive neurons and create the pain im-
pulses. Following such injury, the expression of NR2B
subunit in superficial dorsal horn was detected to
increase significantly [18].
Protein phosphorylation is a major mechanism for the
regulation of receptor activity. Tyr-1472 phosphorylation
of NR2B subunit is important for synaptic plasticity and
the development of central sensitization [19]. Further-
more, tyr-1472 phosphorylation in the superficial dorsal
horn of the spinal cord contributed to the progress of
hyperalgesia in neuropathic pain [20, 21]. Abrupt
withdrawal from opioid use could activate NMDA re-
ceptors and increase postsynaptic calcium concentra-
tions [22]. NMDA antagonist was found to block
increased Tyr1472 phosphorylation and inhibit remifen-
tanil induced hyperalgesia [23].
Mg deficiency could facilitate NMDA receptor activa-
tion and long-term sensitization of the nociceptive path-
ways [11]. Previous study has showed that intrathecal
administration of MgSO4 was beneficial in rats with
NMDA receptor-dependent hyperalgesia [15].
Our findings support our hypothesis that NR2B tyro-
sine phosphorylation could be alleviated by NMDA an-
tagonists. However, direct evidence of magnesium to the
NR2B tyrosine phosphorylation and hyperalgesia remains
to be further explored. It is the first study to demon-
strate that magnesium could prevent RIH via decreasing
Tyr-1472 phosphorylation in NMDA receptor.
Sevoflurane was previously proved to have no influ-
ence on nociceptive thresholds, so it was used for
anesthesia and animal sacrifice in this study [24]. The
doses of MgSO4 employed in the trial was based on the
previous study [9]. Limitations:
1. NMDA receptors are positioned in either cellular
membrane or cytoplasm. In the previous study, it
was demonstrated that membrane trafficking of
NR2B subunits in the spinal cord were significantly
promoted after remifentanil infusion [25]. Due to
inadequate funding, we only extracted the total
protein for western blot analysis. In the further
study, we should extract the membrane protein of
dorsal horn to detect the amount of pNR2B subunits
after magnesium intervention.
2. Sole surgical incision can also induce hyperalgesia
after operation. Why the hyperalgesia in the paper
was attributed to the remifentanil infusion? Previous
report from our research have demonstrated that
remifentanil infusion alone could trigger more
severe hyperalgesia than surgical incision alone [9].
In the figure, the experiment indicated that MgSO4
could inhibit RIH with statistical difference.
However, in the Group RIM3 and Group RIM1, the
thresholds of the behavior tests in the Fig. 1 were
found to have the same level compared with the
thresholds in the Group surgical incision alone in
the figure (shown as Additional file 1). In the
incision-absent group, it is virtually impossible to
interpret our results. In order to present the result,
we uploaded a new Figure as (shown as Additional
files 3 and 4) which combined the Group
magnesium in the study and the Group single
incision from the model experiment in our previous
study [9]. Both of the two study were performed by
doc Sun at the same condition. Maybe we have
made over-interpretation of the data. It was afraid
that such differences did not have clinically
meaningful. In conclusion, the increased expression
of NR2B phosphorylation in the spinal dorsal horn
played an important role in the progress of RIH.
Fig. 2 a-b The expression level of tyrosine phosphorylation of NR2B in
superficial spinal cord in each group. L4-L5 segments of spinal cord were
collected at 48 h after the remifentanil infusion. a Bands of Western blot
for pNR2B. β-Actin is a loading control. b Quantification of pNR2B in each
group. Data are expressed as means ± SD. * p< 0.001 compared with
Group RI, # p< 0.001 compared with Group RIM1
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Intrathecal administration of MgSO4 could
dose-dependently diminish RIH via decreasing the
amount of pNR2B in the spinal dorsal horn. This
study offered the potential therapeutic opportunities
of MgSO4 for the management of opioid induced
pain.
Additional files
Additional file 1: Data of PWTL and PWMT values in the study.
(XLS 19 kb)
Additional file 2: Data of ratio of grey values by β-actin in the western
blot. (XLS 19 kb)
Additional file 3: The PWTL and PWMT tests in the previous model
tests from the referred literature (A and B) and the ones after the NMDA
antagonists therapy in this study (C and D). (XLS 18 kb)
Additional file 4: Data of PWTL and PWMT values in the previous
model tests from the referred literature. (TIF 812 kb)
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